share_log
Reuters ·  May 23 17:08
IDEAYA Biosciences Inc: Darovasertib Was Generally Well Tolerated With No Drug-Related Serious Adverse Events
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment